{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T15:51:24Z","timestamp":1792511484996,"version":"4.5.0"},"reference-count":134,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,27]],"date-time":"2023-10-27T00:00:00Z","timestamp":1698364800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2021YFC2300404"],"award-info":[{"award-number":["2021YFC2300404"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82020108032"],"award-info":[{"award-number":["82020108032"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003395","name":"Shanghai Municipal Education Commission","doi-asserted-by":"publisher","award":["202101070007-E00094"],"award-info":[{"award-number":["202101070007-E00094"]}],"id":[{"id":"10.13039\/501100003395","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Global Antimicrobial Resistance"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.jgar.2023.10.019","type":"journal-article","created":{"date-parts":[[2023,11,2]],"date-time":"2023-11-02T17:08:33Z","timestamp":1698944913000},"page":"314-321","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"special_numbering":"C","title":["Understanding fluconazole tolerance in Candida albicans: implications for effective treatment of candidiasis and combating invasive fungal infections"],"prefix":"10.1016","volume":"35","author":[{"given":"Yanru","family":"Feng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6619-7983","authenticated-orcid":false,"given":"Malcolm","family":"Whiteway","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanying","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jgar.2023.10.019_bib0001","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/978-1-4939-6515-1_2","article-title":"The changing epidemiology of invasive fungal infections","volume":"1508","author":"Enoch","year":"2017","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.jgar.2023.10.019_bib0002","doi-asserted-by":"crossref","first-page":"103953","DOI":"10.1016\/j.isci.2022.103953","article-title":"The role of Candida albicans stress response pathways in antifungal tolerance and resistance","volume":"25","author":"Iyer","year":"2022","journal-title":"iScience"},{"key":"10.1016\/j.jgar.2023.10.019_bib0003","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1146\/annurev-micro-030117-020345","article-title":"Molecular evolution of antifungal drug resistance","volume":"71","author":"Robbins","year":"2017","journal-title":"Annu Rev Microbiol"},{"key":"10.1016\/j.jgar.2023.10.019_bib0004","doi-asserted-by":"crossref","first-page":"441","DOI":"10.2217\/fmb.11.19","article-title":"Current perspectives on echinocandin class drugs","volume":"6","author":"Perlin","year":"2011","journal-title":"Future Microbiol"},{"key":"10.1016\/j.jgar.2023.10.019_bib0005","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1080\/1040841X.2021.1884641","article-title":"Candida albicans targets that potentially synergize with fluconazole","volume":"47","author":"Lu","year":"2021","journal-title":"Crit Rev Microbiol"},{"key":"10.1016\/j.jgar.2023.10.019_bib0006","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/s41579-019-0322-2","article-title":"Drug resistance and tolerance in fungi","volume":"18","author":"Berman","year":"2020","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.jgar.2023.10.019_bib0007","doi-asserted-by":"crossref","first-page":"2470","DOI":"10.1038\/s41467-018-04926-x","article-title":"Antifungal tolerance is a subpopulation effect distinct from resistance and is associated with persistent candidemia","volume":"9","author":"Rosenberg","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.jgar.2023.10.019_bib0008","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/myc.13191","article-title":"Impact of tolerance to fluconazole on treatment response in Candida albicans bloodstream infection","volume":"64","author":"Levinson","year":"2021","journal-title":"Mycoses"},{"key":"10.1016\/j.jgar.2023.10.019_bib0009","doi-asserted-by":"crossref","first-page":"e624","DOI":"10.1016\/j.ijid.2012.11.020","article-title":"Persistent candidemia in neonatal care units: risk factors and clinical significance","volume":"17","author":"Hammoud","year":"2013","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.jgar.2023.10.019_bib0010","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2020.591140","article-title":"Identification and characterization of mediators of fluconazole tolerance in Candida albicans","volume":"11","author":"Delarze","year":"2020","journal-title":"Front Microbiol"},{"key":"10.1016\/j.jgar.2023.10.019_bib0011","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1128\/EC.00221-13","article-title":"UPC2 is universally essential for azole antifungal resistance in Candida albicans","volume":"13","author":"Vasicek","year":"2014","journal-title":"Eukaryot Cell"},{"key":"10.1016\/j.jgar.2023.10.019_bib0012","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1126\/science.1118370","article-title":"Hsp90 potentiates the rapid evolution of new traits: drug resistance in diverse fungi","volume":"309","author":"Cowen","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.jgar.2023.10.019_bib0013","doi-asserted-by":"crossref","first-page":"28831","DOI":"10.1074\/jbc.M303300200","article-title":"Antifungal activity of amiodarone is mediated by disruption of calcium homeostasis","volume":"278","author":"Gupta","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jgar.2023.10.019_bib0014","doi-asserted-by":"crossref","first-page":"e78905","DOI":"10.1371\/journal.pone.0078905","article-title":"Myriocin significantly increases the mortality of a non-mammalian model host during Candida pathogenesis","volume":"8","author":"de Melo","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jgar.2023.10.019_bib0015","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1128\/AAC.44.9.2373-2381.2000","article-title":"Potent synergism of the combination of fluconazole and cyclosporine in Candida albicans","volume":"44","author":"Marchetti","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2023.10.019_bib0016","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.ijantimicag.2013.12.009","article-title":"Combination of fluconazole with non-antifungal agents: a promising approach to cope with resistant Candida albicans infections and insight into new antifungal agent discovery","volume":"43","author":"Liu","year":"2014","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jgar.2023.10.019_bib0017","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s11046-012-9612-1","article-title":"Antifungal activity of geldanamycin alone or in combination with fluconazole against Candida species","volume":"175","author":"Zhang","year":"2013","journal-title":"Mycopathologia"},{"key":"10.1016\/j.jgar.2023.10.019_bib0018","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1016\/j.bmcl.2018.05.044","article-title":"Benzofuro[3,2-d]pyrimidines inspired from cercosporamide CaPkc1 inhibitor: synthesis and evaluation of fluconazole susceptibility restoration","volume":"28","author":"Dao","year":"2018","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.jgar.2023.10.019_bib0019","doi-asserted-by":"crossref","DOI":"10.3390\/md16040133","article-title":"Recent synthesis and discovery of brefeldin A analogs","volume":"16","author":"Paek","year":"2018","journal-title":"Mar Drugs"},{"key":"10.1016\/j.jgar.2023.10.019_bib0020","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01753-20","article-title":"The antifungal and synergistic effect of bisphosphonates in Cryptococcus","volume":"65","author":"Kane","year":"2021","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2023.10.019_bib0021","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1080\/10408398.2017.1381583","article-title":"Lactoferrin: structure, function, denaturation and digestion","volume":"59","author":"Wang","year":"2019","journal-title":"Crit Rev Food Sci Nutr"},{"key":"10.1016\/j.jgar.2023.10.019_bib0022","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1021\/acs.jnatprod.1c01071","article-title":"Solution cis-proline conformation of IPCs inhibitor aureobasidin A elucidated via NMR-based conformational analysis","volume":"85","author":"Gao","year":"2022","journal-title":"J Nat Prod"},{"key":"10.1016\/j.jgar.2023.10.019_bib0023","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.drup.2015.10.001","article-title":"Defining the frontiers between antifungal resistance, tolerance and the concept of persistence","volume":"23","author":"Delarze","year":"2015","journal-title":"Drug Resist Updat"},{"key":"10.1016\/j.jgar.2023.10.019_bib0024","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1099\/mic.0.000295","article-title":"diskImageR: quantification of resistance and tolerance to antimicrobial drugs using disk diffusion assays","volume":"162","author":"Gerstein","year":"2016","journal-title":"Microbiology (Reading)"},{"key":"10.1016\/j.jgar.2023.10.019_bib0025","doi-asserted-by":"crossref","first-page":"3329","DOI":"10.1128\/AAC.00345-07","article-title":"Differential fungicidal activities of amphotericin B and voriconazole against Aspergillus species determined by microbroth methodology","volume":"51","author":"Meletiadis","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2023.10.019_bib0026","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1128\/CMR.17.2.268-280.2004","article-title":"Determination of fungicidal activities against yeasts and molds: lessons learned from bactericidal testing and the need for standardization","volume":"17","author":"Pfaller","year":"2004","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.jgar.2023.10.019_bib0027","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0732-8893(02)00525-4","article-title":"Minimum fungicidal concentrations of amphotericin B for bloodstream Candida species","volume":"45","author":"Cant\u00f3n","year":"2003","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.jgar.2023.10.019_bib0028","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2147\/NSA.S96018","article-title":"Synthesis, characterization, and in vitro activity against Candida spp. of fluconazole encapsulated on cationic and conventional nanoparticles of poly(lactic-co-glycolic acid)","volume":"10","author":"G\u00f3mez-Sequeda","year":"2017","journal-title":"Nanotechnol Sci Appl"},{"key":"10.1016\/j.jgar.2023.10.019_bib0029","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1099\/mic.0.000589","article-title":"A novel mechanism of fluconazole: fungicidal activity through dose-dependent apoptotic responses in Candida albicans","volume":"164","author":"Lee","year":"2018","journal-title":"Microbiology (Reading)"},{"key":"10.1016\/j.jgar.2023.10.019_bib0030","doi-asserted-by":"crossref","first-page":"ofab444","DOI":"10.1093\/ofid\/ofab444","article-title":"Antifungal susceptibility testing: a primer for clinicians","volume":"8","author":"Wiederhold","year":"2021","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.jgar.2023.10.019_bib0031","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1016\/j.cmi.2020.06.007","article-title":"How to interpret MICs of antifungal compounds according to the revised clinical breakpoints v. 10.0 European committee on antimicrobial susceptibility testing (EUCAST)","volume":"26","author":"Arendrup","year":"2020","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jgar.2023.10.019_bib0032","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1128\/AAC.03470-14","article-title":"Contribution of clinically derived mutations in ERG11 to azole resistance in Candida albicans","volume":"59","author":"Flowers","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2023.10.019_bib0033","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01337-18","article-title":"Loss of C-5 sterol desaturase activity in Candida albicans: azole resistance or merely trailing growth?","volume":"63","author":"Luna-Tapia","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2023.10.019_bib0034","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/S0014-5793(96)01360-9","article-title":"Resistance to fluconazole and cross-resistance to amphotericin B in Candida albicans from AIDS patients caused by defective sterol delta5,6-desaturation","volume":"400","author":"Kelly","year":"1997","journal-title":"FEBS Lett"},{"key":"10.1016\/j.jgar.2023.10.019_bib0035","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1128\/EC.00070-08","article-title":"Genomewide location analysis of Candida albicans Upc2p, a regulator of sterol metabolism and azole drug resistance","volume":"7","author":"Znaidi","year":"2008","journal-title":"Eukaryot Cell"},{"key":"10.1016\/j.jgar.2023.10.019_bib0036","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.1128\/AAC.39.11.2378","article-title":"Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters","volume":"39","author":"Sanglard","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2023.10.019_bib0037","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1046\/j.1365-2958.2002.02814.x","article-title":"A common drug-responsive element mediates the upregulation of the Candida albicans ABC transporters CDR1 and CDR2, two genes involved in antifungal drug resistance","volume":"43","author":"de Micheli","year":"2002","journal-title":"Mol Microbiol"},{"issue":"Pt 2","key":"10.1016\/j.jgar.2023.10.019_bib0038","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1099\/00221287-143-2-405","article-title":"Cloning of Candida albicans genes conferring resistance to azole antifungal agents: characterization of CDR2, a new multidrug ABC transporter gene","volume":"143","author":"Sanglard","year":"1997","journal-title":"Microbiology (Reading)"},{"key":"10.1016\/j.jgar.2023.10.019_bib0039","first-page":"61","article-title":"Mediator tail module is required for Tac1-activated CDR1 expression and azole resistance in Candida albicans","author":"Liu","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2023.10.019_bib0040","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1534\/genetics.105.054767","article-title":"A mutation in Tac1p, a transcription factor regulating CDR1 and CDR2, is coupled with loss of heterozygosity at chromosome 5 to mediate antifungal resistance in Candida albicans","volume":"172","author":"Coste","year":"2006","journal-title":"Genetics"},{"key":"10.1016\/j.jgar.2023.10.019_bib0041","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.1101553","article-title":"Myriocin enhances the antifungal activity of fluconazole by blocking the membrane localization of the efflux pump Cdr1","volume":"13","author":"Wang","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jgar.2023.10.019_bib0042","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1128\/AAC.47.8.2404-2412.2003","article-title":"Candida albicans mutations in the ergosterol biosynthetic pathway and resistance to several antifungal agents","volume":"47","author":"Sanglard","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2023.10.019_bib0043","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1080\/1369378032000141471","article-title":"Isolation, characterization, and regulation of the Candida albicans ERG27 gene encoding the sterol 3-keto reductase","volume":"42","author":"Pierson","year":"2004","journal-title":"Med Mycol"},{"key":"10.1016\/j.jgar.2023.10.019_bib0044","article-title":"A small molecule inhibitor of Erg251 makes fluconazole fungicidal by inhibiting the synthesis of the 14alpha-methylsterols","author":"Lu","year":"2022","journal-title":"mBio"},{"key":"10.1016\/j.jgar.2023.10.019_bib0045","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22105219","article-title":"Lactate like fluconazole reduces ergosterol content in the plasma membrane and synergistically kills Candida albicans","volume":"22","author":"Suchodolski","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"Suppl 1","key":"10.1016\/j.jgar.2023.10.019_bib0046","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.1093\/ofid\/ofy358","article-title":"Twenty years of the SENTRY antifungal surveillance program: results for Candida species from 1997-2016","volume":"6","author":"Pfaller","year":"2019","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.jgar.2023.10.019_bib0047","article-title":"Antifungal pharmacokinetics and pharmacodynamics","volume":"5","author":"Lepak","year":"2014","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.jgar.2023.10.019_bib0048","doi-asserted-by":"crossref","first-page":"3149","DOI":"10.1128\/AAC.47.10.3149-3154.2003","article-title":"Antifungal susceptibility survey of 2,000 bloodstream Candida isolates in the United States","volume":"47","author":"Ostrosky-Zeichner","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2023.10.019_bib0049","doi-asserted-by":"crossref","first-page":"e28666","DOI":"10.5812\/jjm.28666","article-title":"In vitro susceptibility and trailing growth effect of clinical isolates of Candida species to azole drugs","volume":"9","author":"Zomorodian","year":"2016","journal-title":"Jundishapur J Microbiol"},{"key":"10.1016\/j.jgar.2023.10.019_bib0050","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1093\/mmy\/myw033","article-title":"Scope and frequency of fluconazole trailing assessed using EUCAST in invasive Candida spp. isolates","volume":"54","author":"Marcos-Zambrano","year":"2016","journal-title":"Med Mycol"},{"key":"10.1016\/j.jgar.2023.10.019_bib0051","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmi.2016.09.016","article-title":"Evaluation of the possible influence of trailing and paradoxical effects on the clinical outcome of patients with candidemia","volume":"23","author":"Rueda","year":"2017","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jgar.2023.10.019_bib0052","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1128\/AAC.46.8.2477-2481.2002","volume":"46","author":"Arthington-Skaggs","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2023.10.019_bib0053","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1128\/AAC.42.1.129","article-title":"Optimizing the correlation between results of testing in vitro and therapeutic outcome in vivo for fluconazole by testing critical isolates in a murine model of invasive candidiasis","volume":"42","author":"Rex","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2023.10.019_bib0054","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1128\/AAC.44.8.2081-2085.2000","article-title":"Quantitation of Candida albicans ergosterol content improves the correlation between in vitro antifungal susceptibility test results and in vivo outcome after fluconazole treatment in a murine model of invasive candidiasis","volume":"44","author":"Arthington-Skaggs","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2023.10.019_bib0055","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.3389\/fmicb.2018.01196","article-title":"The impact of biofilm formation on the persistence of candidemia","volume":"9","author":"Li","year":"2018","journal-title":"Front Microbiol"},{"key":"10.1016\/j.jgar.2023.10.019_bib0056","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.ijid.2003.05.003","article-title":"The predictors of outcome in immunocompetent patients with hematogenous candidiasis","volume":"8","author":"Safdar","year":"2004","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.jgar.2023.10.019_bib0057","doi-asserted-by":"crossref","first-page":"2932","DOI":"10.1128\/AAC.44.11.2932-2938.2000","article-title":"Fluconazole plus cyclosporine: a fungicidal combination effective against experimental endocarditis due to Candida albicans","volume":"44","author":"Marchetti","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2023.10.019_bib0058","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000753","article-title":"Reverse genetics in Candida albicans predicts ARF cycling is essential for drug resistance and virulence","volume":"6","author":"Epp","year":"2010","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.jgar.2023.10.019_bib0059","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1093\/jac\/dkh040","article-title":"Drug resistance genes and trailing growth in Candida albicans isolates","volume":"53","author":"Lee","year":"2004","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jgar.2023.10.019_bib0060","doi-asserted-by":"crossref","first-page":"3585","DOI":"10.1128\/AAC.00294-13","article-title":"Potentiation of azole antifungals by 2-adamantanamine","volume":"57","author":"Lafleur","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2023.10.019_bib0061","doi-asserted-by":"crossref","first-page":"4527","DOI":"10.1128\/AAC.00348-10","article-title":"Identification and characterization of four azole-resistant erg3 mutants of Candida albicans","volume":"54","author":"Martel","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2023.10.019_bib0062","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00084-17","article-title":"An azole-tolerant endosomal trafficking mutant of Candida albicans is susceptible to azole treatment in a mouse model of vaginal candidiasis","volume":"61","author":"Peters","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2023.10.019_bib0063","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1006\/bbrc.1995.1272","article-title":"Mode of action and resistance to azole antifungals associated with the formation of 14 alpha-methylergosta-8,24(28)-dien-3 beta,6 alpha-diol","volume":"207","author":"Kelly","year":"1995","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jgar.2023.10.019_bib0064","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/0006-291X(89)91792-0","article-title":"Defective sterol C5-6 desaturation and azole resistance: a new hypothesis for the mode of action of azole antifungals","volume":"164","author":"Watson","year":"1989","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jgar.2023.10.019_bib0065","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005188","article-title":"Disruption of sphingolipid biosynthesis blocks phagocytosis of Candida albicans","volume":"11","author":"Tafesse","year":"2015","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.jgar.2023.10.019_bib0066","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2019.12.022","article-title":"The regulatory proteins Rtg1\/3 govern sphingolipid homeostasis in the human-associated yeast Candida albicans","volume":"30","author":"Moreno-Vel\u00e1squez","year":"2020","journal-title":"Cell Rep"},{"key":"10.1016\/j.jgar.2023.10.019_bib0067","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1080\/14787210.2020.1792288","article-title":"Fungal sphingolipids: role in the regulation of virulence and potential as targets for future antifungal therapies","volume":"18","author":"Mota Fernandes","year":"2020","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.jgar.2023.10.019_bib0068","doi-asserted-by":"crossref","first-page":"856","DOI":"10.3390\/pathogens10070856","article-title":"Sphingolipid inhibitors as an alternative to treat candidiasis caused by fluconazole-resistant strains","volume":"10","author":"Rollin-Pinheiro","year":"2021","journal-title":"Pathogens"},{"key":"10.1016\/j.jgar.2023.10.019_bib0069","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0925-4439(99)00097-6","article-title":"Inositol phosphoryl transferases from human pathogenic fungi","volume":"1500","author":"Heidler","year":"2000","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.jgar.2023.10.019_bib0070","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006205","article-title":"Role of Arf GTPases in fungal morphogenesis and virulence","volume":"13","author":"Labbaoui","year":"2017","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.jgar.2023.10.019_bib0071","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1146\/annurev.genet.35.102401.091302","article-title":"Genetic analysis of calmodulin and its targets in Saccharomyces cerevisiae","volume":"35","author":"Cyert","year":"2001","journal-title":"Annu Rev Genet"},{"key":"10.1016\/j.jgar.2023.10.019_bib0072","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1093\/emboj\/21.4.546","article-title":"Calcineurin is essential for survival during membrane stress in Candida albicans","volume":"21","author":"Cruz","year":"2002","journal-title":"EMBO J"},{"key":"10.1016\/j.jgar.2023.10.019_bib0073","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1046\/j.1365-2958.2003.03495.x","article-title":"Calcineurin A of Candida albicans: involvement in antifungal tolerance, cell morphogenesis and virulence","volume":"48","author":"Sanglard","year":"2003","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.jgar.2023.10.019_bib0074","doi-asserted-by":"crossref","DOI":"10.1016\/j.micres.2021.126786","article-title":"Calcium-calcineurin signaling pathway in Candida albicans: a potential drug target","volume":"249","author":"Li","year":"2021","journal-title":"Microbiol Res"},{"key":"10.1016\/j.jgar.2023.10.019_bib0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12964-019-0473-9","article-title":"RNA sequencing reveals an additional Crz1-binding motif in promoters of its target genes in the human fungal pathogen Candida albicans","volume":"18","author":"Xu","year":"2020","journal-title":"Cell Commun Signal"},{"key":"10.1016\/j.jgar.2023.10.019_bib0076","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1111\/j.1365-2958.2005.05037.x","article-title":"CRZ1, a target of the calcineurin pathway in Candida albicans","volume":"59","author":"Karababa","year":"2006","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.jgar.2023.10.019_bib0077","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3389\/fcimb.2018.00185","article-title":"Iron at the centre of Candida albicans interactions","volume":"8","author":"Fourie","year":"2018","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.jgar.2023.10.019_bib0078","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamcr.2020.118797","article-title":"Adaptation to iron deficiency in human pathogenic fungi","volume":"1867","author":"Mart\u00ednez-Pastor","year":"2020","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"10.1016\/j.jgar.2023.10.019_bib0079","doi-asserted-by":"crossref","DOI":"10.1128\/aac.00725-22","article-title":"Synergistic effect of the combination of deferoxamine and fluconazole in vitro and in vivo against fluconazole-resistant Candida spp","volume":"66","author":"An","year":"2022","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2023.10.019_bib0080","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.01951-21","article-title":"Selective metal chelation by a thiosemicarbazone derivative interferes with mitochondrial respiration and ribosome biogenesis in Candida albicans","volume":"10","author":"Duan","year":"2022","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.jgar.2023.10.019_bib0081","doi-asserted-by":"crossref","first-page":"3785","DOI":"10.1128\/AAC.06017-11","article-title":"Potent synergistic effect of doxycycline with fluconazole against Candida albicans is mediated by interference with iron homeostasis","volume":"56","author":"Fiori","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"issue":"Pt 9","key":"10.1016\/j.jgar.2023.10.019_bib0082","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1099\/jmm.0.2008\/001263-0","article-title":"Human recombinant lactoferrin acts synergistically with antimicrobials commonly used in neonatal practice against coagulase-negative staphylococci and Candida albicans causing neonatal sepsis","volume":"57","author":"Venkatesh","year":"2008","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.jgar.2023.10.019_bib0083","doi-asserted-by":"crossref","first-page":"3597","DOI":"10.1128\/AAC.00653-06","article-title":"Unexpected link between iron and drug resistance of Candida spp.: iron depletion enhances membrane fluidity and drug diffusion, leading to drug-susceptible cells","volume":"50","author":"Prasad","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2023.10.019_bib0084","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jare.2021.06.016","article-title":"Hinokitiol chelates intracellular iron to retard fungal growth by disturbing mitochondrial respiration","volume":"34","author":"Jin","year":"2021","journal-title":"J Adv Res"},{"key":"10.1016\/j.jgar.2023.10.019_bib0085","doi-asserted-by":"crossref","first-page":"e18684","DOI":"10.1371\/journal.pone.0018684","article-title":"Calcineurin signaling and membrane lipid homeostasis regulates iron mediated multidrug resistance mechanisms in Candida albicans","volume":"6","author":"Hameed","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.jgar.2023.10.019_bib0086","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.bbamcr.2013.12.009","article-title":"Cellular iron homeostasis mediated by the Mrs4-Ccc1-Smf3 pathway is essential for mitochondrial function, morphogenesis and virulence in Candida albicans","volume":"1843","author":"Xu","year":"2014","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.jgar.2023.10.019_bib0087","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1007\/BF01967067","article-title":"Effects of fluconazole on the sterol and carbohydrate composition of four species of Candida","volume":"11","author":"Pfaller","year":"1992","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.jgar.2023.10.019_bib0088","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1111\/j.1365-2958.2007.05588.x","article-title":"The PKC, HOG and Ca2+ signalling pathways co-ordinately regulate chitin synthesis in Candida albicans","volume":"63","author":"Munro","year":"2007","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.jgar.2023.10.019_bib0089","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.bcp.2016.11.019","article-title":"Antifungals","volume":"133","author":"Campoy","year":"2017","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.jgar.2023.10.019_bib0090","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/msb.2011.31","article-title":"Cross-species discovery of syncretic drug combinations that potentiate the antifungal fluconazole","volume":"7","author":"Spitzer","year":"2011","journal-title":"Mol Syst Biol"},{"key":"10.1016\/j.jgar.2023.10.019_bib0091","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1111\/cmi.12612","article-title":"Cell wall integrity signalling in human pathogenic fungi","volume":"18","author":"Dichtl","year":"2016","journal-title":"Cell Microbiol"},{"key":"10.1016\/j.jgar.2023.10.019_bib0092","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1001069","article-title":"PKC signaling regulates drug resistance of the fungal pathogen Candida albicans via circuitry comprised of Mkc1, calcineurin, and Hsp90","volume":"6","author":"LaFayette","year":"2010","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.jgar.2023.10.019_bib0093","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1371\/journal.ppat.0020021","article-title":"Control of the C. albicans cell wall damage response by transcriptional regulator Cas5","volume":"2","author":"Bruno","year":"2006","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.jgar.2023.10.019_bib0094","doi-asserted-by":"crossref","first-page":"6807","DOI":"10.1128\/AAC.00064-14","article-title":"Disruption of the transcriptional regulator Cas5 results in enhanced killing of Candida albicans by fluconazole","volume":"58","author":"Vasicek","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2023.10.019_bib0095","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1093\/mmy\/myaa080","article-title":"The assimilation of different carbon sources in Candida albicans: fitness and pathogenicity","volume":"59","author":"Lok","year":"2021","journal-title":"Med Mycol"},{"key":"10.1016\/j.jgar.2023.10.019_bib0096","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1111\/j.1462-5822.2012.01813.x","article-title":"Host carbon sources modulate cell wall architecture, drug resistance and virulence in a fungal pathogen","volume":"14","author":"Ene","year":"2012","journal-title":"Cell Microbiol"},{"key":"10.1016\/j.jgar.2023.10.019_bib0097","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1099\/jmm.0.47168-0","article-title":"Trailing end-point phenotype of Candida spp. in antifungal susceptibility testing to fluconazole is eliminated by altering incubation temperature","volume":"56","author":"Agrawal","year":"2007","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.jgar.2023.10.019_bib0098","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1111\/j.1567-1364.2012.00822.x","article-title":"Candida albicans Msi3p, a homolog of the Saccharomyces cerevisiae Sse1p of the Hsp70 family, is involved in cell growth and fluconazole tolerance","volume":"12","author":"Nagao","year":"2012","journal-title":"FEMS Yeast Res"},{"key":"10.1016\/j.jgar.2023.10.019_bib0099","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1146\/annurev.biochem.75.103004.142738","article-title":"Structure and mechanism of the Hsp90 molecular chaperone machinery","volume":"75","author":"Pearl","year":"2006","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.jgar.2023.10.019_bib0100","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/nrm.2017.20","article-title":"The HSP90 chaperone machinery","volume":"18","author":"Schopf","year":"2017","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.jgar.2023.10.019_bib0101","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000532","article-title":"Hsp90 governs echinocandin resistance in the pathogenic yeast Candida albicans via calcineurin","volume":"5","author":"Singh","year":"2009","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.jgar.2023.10.019_bib0102","first-page":"220","article-title":"Genetic analysis of Hsp90 function in Cryptococcus neoformans highlights key roles in stress tolerance and virulence","author":"Fu","year":"2022","journal-title":"Genetics"},{"key":"10.1016\/j.jgar.2023.10.019_bib0103","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3000358","article-title":"Global proteomic analyses define an environmentally contingent Hsp90 interactome and reveal chaperone-dependent regulation of stress granule proteins and the R2TP complex in a fungal pathogen","volume":"17","author":"O\u2019Meara","year":"2019","journal-title":"PLoS Biol"},{"key":"10.1016\/j.jgar.2023.10.019_bib0104","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000471","article-title":"Hsp90 orchestrates stress response signaling governing fungal drug resistance","volume":"5","author":"Cowen","year":"2009","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.jgar.2023.10.019_bib0105","doi-asserted-by":"crossref","first-page":"3626","DOI":"10.1038\/s41467-019-11518-w","article-title":"The Hsp90 isoforms from S. cerevisiae differ in structure, function and client range","volume":"10","author":"Girstmair","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.jgar.2023.10.019_bib0106","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1128\/EC.00096-14","article-title":"Ascorbic acid inhibition of Candida albicans Hsp90-mediated morphogenesis occurs via the transcriptional regulator Upc2","volume":"13","author":"Van Hauwenhuyse","year":"2014","journal-title":"Eukaryot Cell"},{"key":"10.1016\/j.jgar.2023.10.019_bib0107","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002257","article-title":"Hsp90 governs dispersion and drug resistance of fungal biofilms","volume":"7","author":"Robbins","year":"2011","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.jgar.2023.10.019_bib0108","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1128\/AAC.43.6.1383","article-title":"The trailing end point phenotype in antifungal susceptibility testing is pH dependent","volume":"43","author":"Marr","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2023.10.019_bib0109","first-page":"62","article-title":"The rim pathway mediates antifungal tolerance in Candida albicans through newly identified Rim101 transcriptional targets, including Hsp90 and Ipt1","author":"Garnaud","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2023.10.019_bib0110","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.00227-23","article-title":"Antifungal tolerance and resistance emerge at distinct drug concentrations and rely upon different aneuploid chromosomes","author":"Yang","year":"2023","journal-title":"mBio"},{"key":"10.1016\/j.jgar.2023.10.019_bib0111","article-title":"Aneuploidy mediates rapid adaptation to a subinhibitory amount of fluconazole in Candida albicans","author":"Sun","year":"2023","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.jgar.2023.10.019_bib0112","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1093\/molbev\/msz104","article-title":"Aneuploidy enables cross-adaptation to unrelated drugs","volume":"36","author":"Yang","year":"2019","journal-title":"Mol Biol Evol"},{"key":"10.1016\/j.jgar.2023.10.019_bib0113","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.02272-21","article-title":"Tunicamycin potentiates antifungal drug tolerance via aneuploidy in Candida albicans","volume":"12","author":"Yang","year":"2021","journal-title":"mBio"},{"key":"10.1016\/j.jgar.2023.10.019_bib0114","first-page":"12","article-title":"Acquisition of cross-azole tolerance and aneuploidy in Candida albicans strains evolved to posaconazole","author":"Kukurudz","year":"2022","journal-title":"G3 (Bethesda)"},{"key":"10.1016\/j.jgar.2023.10.019_bib0115","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/jam.14949","article-title":"Biofilm of Candida albicans: formation, regulation and resistance","volume":"131","author":"Pereira","year":"2021","journal-title":"J Appl Microbiol"},{"key":"10.1016\/j.jgar.2023.10.019_bib0116","doi-asserted-by":"crossref","first-page":"5385","DOI":"10.1128\/JB.183.18.5385-5394.2001","article-title":"Biofilm formation by the fungal pathogen Candida albicans: development, architecture, and drug resistance","volume":"183","author":"Chandra","year":"2001","journal-title":"J Bacteriol"},{"key":"10.1016\/j.jgar.2023.10.019_bib0117","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1128\/AAC.05290-11","article-title":"Possible inhibitory molecular mechanism of farnesol on the development of fluconazole resistance in Candida albicans biofilm","volume":"56","author":"Yu","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2023.10.019_bib0118","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/nbt919","article-title":"Integration of chemical-genetic and genetic interaction data links bioactive compounds to cellular target pathways","volume":"22","author":"Parsons","year":"2004","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.jgar.2023.10.019_bib0119","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1038\/ng1640","article-title":"The synthetic genetic interaction spectrum of essential genes","volume":"37","author":"Davierwala","year":"2005","journal-title":"Nat Genet"},{"key":"10.1016\/j.jgar.2023.10.019_bib0120","doi-asserted-by":"crossref","first-page":"33 8","DOI":"10.1038\/msb.2009.95","article-title":"Chemogenomic profiling predicts antifungal synergies","volume":"5","author":"Jansen","year":"2009","journal-title":"Mol Syst Biol"},{"key":"10.1016\/j.jgar.2023.10.019_bib0121","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/s41564-017-0043-0","article-title":"A CRISPR-Cas9-based gene drive platform for genetic interaction analysis in Candida albicans","volume":"3","author":"Shapiro","year":"2018","journal-title":"Nat Microbiol"},{"key":"10.1016\/j.jgar.2023.10.019_bib0122","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1080\/21505594.2016.1196300","article-title":"Combinatorial strategies for combating invasive fungal infections","volume":"8","author":"Spitzer","year":"2017","journal-title":"Virulence"},{"key":"10.1016\/j.jgar.2023.10.019_bib0123","doi-asserted-by":"crossref","first-page":"3337","DOI":"10.1128\/AAC.01564-08","article-title":"Antifungal activity of tamoxifen: in vitro and in vivo activities and mechanistic characterization","volume":"53","author":"Dolan","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2023.10.019_bib0124","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1152\/physrev.2000.80.4.1483","article-title":"Calcineurin: form and function","volume":"80","author":"Rusnak","year":"2000","journal-title":"Physiol Rev"},{"key":"10.1016\/j.jgar.2023.10.019_bib0125","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.plipres.2015.11.001","article-title":"Unraveling the role of the target of rapamycin signaling in sphingolipid metabolism","volume":"61","author":"Teixeira","year":"2016","journal-title":"Prog Lipid Res"},{"key":"10.1016\/j.jgar.2023.10.019_bib0126","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1023\/B:MYCO.0000024182.04140.95","article-title":"Inhibition of serine palmitoyltransferase by myriocin, a natural mycotoxin, causes induction of c-myc in mouse liver","volume":"157","author":"He","year":"2004","journal-title":"Mycopathologia"},{"key":"10.1016\/j.jgar.2023.10.019_bib0127","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1093\/oxfordjournals.jbchem.a129827","article-title":"The action mechanism of cerulenin. I. Effect of cerulenin on sterol and fatty acid biosynthesis in yeast","volume":"71","author":"Nomura","year":"1972","journal-title":"J Biochem"},{"key":"10.1016\/j.jgar.2023.10.019_bib0128","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1111\/apm.12031","article-title":"3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitor (fluvastatin) decreases inflammatory angiogenesis in mice","volume":"121","author":"Araujo","year":"2013","journal-title":"APMIS"},{"key":"10.1016\/j.jgar.2023.10.019_bib0129","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1007\/s10156-013-0639-0","article-title":"Combinatory effect of fluconazole and FDA-approved drugs against Candida albicans","volume":"19","author":"Kaneko","year":"2013","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.jgar.2023.10.019_bib0130","doi-asserted-by":"crossref","first-page":"e00504","DOI":"10.1128\/AAC.00504-18","article-title":"Commonly used oncology drugs decrease antifungal effectiveness against Candida and Aspergillus species","volume":"62","author":"Butts","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2023.10.019_bib0131","doi-asserted-by":"crossref","first-page":"7525","DOI":"10.1038\/s41598-020-64571-7","article-title":"Repurposing approach identifies pitavastatin as a potent azole chemosensitizing agent effective against azole-resistant Candida species","volume":"10","author":"Eldesouky","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.jgar.2023.10.019_bib0132","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00684-20","article-title":"Potent synergistic interactions between lopinavir and azole antifungal drugs against emerging multidrug-resistant Candida auris","volume":"65","author":"Eldesouky","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2023.10.019_bib0133","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1128\/AAC.48.3.693-715.2004","article-title":"Combination antifungal therapy","volume":"48","author":"Johnson","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2023.10.019_bib0134","author":"Dumeaux","year":"2022","journal-title":"Candida albicans exhibits heterogeneous and adaptive cytoprotective responses to anti-fungal compounds"}],"container-title":["Journal of Global Antimicrobial Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716523001881?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716523001881?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:01:03Z","timestamp":1761991263000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213716523001881"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":134,"alternative-id":["S2213716523001881"],"URL":"https:\/\/doi.org\/10.1016\/j.jgar.2023.10.019","relation":{},"ISSN":["2213-7165"],"issn-type":[{"value":"2213-7165","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Understanding fluconazole tolerance in Candida albicans: implications for effective treatment of candidiasis and combating invasive fungal infections","name":"articletitle","label":"Article Title"},{"value":"Journal of Global Antimicrobial Resistance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jgar.2023.10.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Ltd on behalf of International Society for Antimicrobial Chemotherapy.","name":"copyright","label":"Copyright"}]}}